Redeye: Nuevolution - Strengthening the foundation & Cytokine X unveiled
The second quarter showed stable operational progress for Nuevolution and the company also completed a directed share issue as well as an up-listing to the Nasdaq Stockholm main market, improving the company's foundation.
Read more and download the research update: http://bit.ly/2LYGboP
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/